In 2022, a Dutch long-term care insurance pool notified policyholders that monthly benefits would be capped, effective immediately. The reason: German morbidity tables had been updated, and the pool's solvency ratio had fallen below the required threshold. The product, marketed as a Dutch solution for aging-related care costs, was priced using German actuarial tables—a dependency that few policyholders knew existed. This case study examines how a shift in German morbidity assumptions triggered a cascade of benefit reductions, legal challenges, and regulatory scrutiny in the Netherlands, raising broader questions about cross-jurisdiction product design.

When German Actuarial Tables Triggered a Dutch Payout Cap

The pool in question, a group long-term care policy sold to roughly 15,000 Dutch residents, had been priced using the German DAV 2004R morbidity tables. These tables, developed by the German Actuarial Association, were standard for private LTC insurance in Germany but had no direct connection to Dutch morbidity experience. When the DAV updated its tables in 2018 to the DAV 2018R, the revision projected higher claim frequencies—roughly 15–20% higher, according to a 2020 analysis by the Dutch Actuarial Society.

The pool's solvency ratio, which had hovered around 135% before the revision, dropped below the Dutch regulatory threshold of 125% once the new tables were applied to reserve calculations. The administrator, a Dutch subsidiary of a European insurer, announced a temporary cap on monthly benefits: new claims would be limited to €1,100 per month, down from the original €1,500. Existing claimants saw their annual inflation adjustments capped at 1% rather than the full CPI-linked increase.

The cap was applied retroactively to all in-force policies, a move that surprised many policyholders. The product's terms had included a clause allowing benefit adjustments if the underlying morbidity assumptions proved materially inaccurate, but few had read the fine print. By mid-2023, the cap had affected roughly 400 new claimants and limited increases for 1,200 existing recipients.

Consumer groups argued that the retroactive application was unfair, but the insurer maintained that the solvency risk justified the action. A 2022 KPMG audit estimated the reserve shortfall at €40–60 million, driven entirely by the table revision. The pool had no premium-adjustment mechanism, leaving benefit reduction as the only tool to restore solvency.

Cross-Border Pricing Dependency Rarely Disclosed

The Dutch LTC pool's reliance on German tables was not unique, but it was unusually opaque. Similar products sold in Belgium and France typically use local morbidity tables—Belgium's CBFA tables or France's TGH/TGF—which reflect local care utilization patterns. The Dutch product, however, had been designed by a German reinsurer that bundled its own morbidity assumptions without market-specific adjustments.

The Dutch regulator, the Authority for Financial Markets (AFM), had not required explicit disclosure of the table jurisdiction in product prospectuses. A 2019 white paper by the Dutch Actuarial Society had flagged the risk of cross-border table dependency, but it was largely ignored by the industry. The white paper noted that Dutch morbidity experience differed from German experience by as much as 10–15% for certain age cohorts, yet no adjustment was made.

Reinsurers, which often provide the underlying morbidity tables for such products, typically offer standardized global tables without jurisdiction-specific calibration. This practice, while cost-efficient for the reinsurer, shifts the basis risk to the primary insurer and ultimately to policyholders. In this case, the German tables were designed for a market with higher private LTC penetration and different care norms, making them a poor fit for the Dutch context.

The lack of disclosure meant that policyholders had no way to evaluate the risk that their benefits could be reduced based on morbidity trends in another country. A 2023 survey by the Consumentenbond found that 78% of policyholders in the pool were unaware that German tables were used for pricing. The case has since prompted the AFM to consider new disclosure rules for cross-border actuarial dependencies.

The Morbidity Shift That Broke the Model

The DAV 2004R tables had been in use since 2005, but by 2018, German private LTC insurers had observed higher disability incidence than the tables predicted. The DAV 2018R revision increased morbidity rates by roughly 15–20% for ages 65–80, reflecting longer life expectancies and higher rates of chronic conditions. German insurers responded by raising premiums by 12–18% after 2020, as reported by the German Insurance Association.

The Dutch pool, however, had no premium-adjustment mechanism. Its policy terms allowed only benefit adjustments, and even those were limited to cases of "material adverse deviation" in morbidity assumptions. The 2018 revision qualified as such, but the pool's administrator had not stress-tested the product under foreign table shifts. The reserve shortfall, estimated by KPMG at €40–60 million, represented roughly 20% of the pool's total liabilities.

Some actuaries argue that the pool should have used Dutch-specific tables from the start. The Dutch Actuarial Society's 2019 white paper had recommended that products marketed to Dutch residents use local morbidity data, even if priced by a foreign reinsurer. But the pool's administrator had opted for German tables because they were more readily available and had a longer track record in LTC pricing.

The shift also exposed a flaw in the reinsurance structure. The German reinsurer that provided the tables had not guaranteed the accuracy of the assumptions for the Dutch market. When the tables changed, the reinsurer did not share in the shortfall, leaving the primary insurer to absorb the loss. This asymmetry is common in cross-border reinsurance treaties, where the cedent bears the basis risk.

Policyholder Impact and Legal Challenges

The cap on benefits had immediate financial consequences for policyholders. New claimants seeking LTC benefits saw their monthly payout drop from €1,500 to €1,100—a 27% reduction. For a policyholder requiring home care, this could mean fewer hours of professional care or a shift to informal family caregiving. Existing claimants, who had expected annual inflation adjustments of 2–3%, received capped increases of 1%, eroding their real benefits over time.

The Consumentenbond, a Dutch consumer organization, filed a complaint with the AFM in 2023, arguing that the retroactive cap violated principles of good faith and fair dealing. The complaint cited a 2019 European Insurance and Occupational Pensions Authority (EIOPA) opinion that benefit reductions should be prospective only, unless the policy explicitly allows retroactive changes. The AFM launched an investigation but has not yet issued a ruling.

Dutch courts, however, have so far upheld the cap. In a 2024 ruling, a district court in Utrecht found that the force majeure clause in the policy terms—which allowed adjustments due to "unforeseeable changes in actuarial assumptions"—covered the table revision. The court noted that the insurer had provided 60 days' notice before implementing the cap, as required by Dutch insurance law.

The Dutch case contrasts with similar situations in Germany, where regulators allowed insurers to raise premiums rather than cut benefits. German LTC insurers, facing the same table revision, increased premiums by an average of 15% over three years, with policyholders given the option to reduce coverage instead. The difference highlights how regulatory frameworks shape the allocation of risk between insurers and policyholders across jurisdictions.

Lessons for Cross-Jurisdiction Product Design

The Dutch LTC pool case offers several lessons for insurers and regulators. First, regulators should mandate disclosure of the jurisdiction of actuarial tables used in pricing. The AFM is now considering a rule that would require prospectuses to state which country's morbidity data underlies the product, along with a summary of key differences from local experience. This would allow consumers and advisors to assess basis risk.

Second, products with fixed benefits need explicit repricing triggers. The Dutch pool's lack of a premium-adjustment mechanism left benefit cuts as the only option. Insurers designing cross-border products should include both premium and benefit adjustment clauses, with clear conditions for their activation. The European Insurance and Occupational Pensions Authority (EIOPA) has no cross-border morbidity standard, but a 2023 consultation paper suggested that such standards could reduce systemic risk.

Third, reinsurance treaties should include jurisdiction-specific experience adjustment clauses. The German reinsurer in this case did not adjust the tables for Dutch morbidity patterns, nor did it share in the shortfall when the tables changed. Treaties that require the reinsurer to provide local-calibrated tables or to absorb a portion of the basis risk would align incentives more closely.

Finally, policyholder notification requirements should be strengthened. The pool's administrator notified policyholders 60 days before the cap took effect, but many felt blindsided. A 30-day notification requirement for material changes to actuarial assumptions, as proposed by the Dutch Actuarial Society, would give policyholders more time to seek alternatives. Some consumer advocates argue that policyholders should have the right to cancel without penalty if the product's pricing basis changes materially.

What Insurers Can Do to Avoid a Repeat

Insurers can take several practical steps to avoid similar situations. Before launching a cross-jurisdiction product, they should build multi-jurisdiction morbidity models that compare local and foreign tables under various scenarios. This would reveal the sensitivity of reserves to table jurisdiction and help set appropriate capital buffers.

Automatic premium-adjustment or benefit-adjustment clauses should be built into policy terms from the start. The Dutch pool's experience shows that fixed-benefit products without adjustment mechanisms are fragile when underlying assumptions shift. A clause that triggers a review when a specified morbidity index changes by more than 10% could provide a structured response.

Annual stress-testing of solvency under foreign table shifts should become standard practice. The pool's administrator had not modeled the impact of a German table revision, despite the product's explicit link to DAV tables. A simple scenario analysis—what if the German tables are revised upward by 15%?—would have revealed the vulnerability.

Offering policyholders a one-time option to switch to a product based on local tables could also mitigate risk. This would allow those who prefer local pricing to opt out of the cross-border structure. The pool's administrator has not offered such an option, but it is being discussed in the AFM's ongoing review.

Transparency reports on table provenance and revision frequency would help advisors and consumers make informed choices. The Dutch Actuarial Society has proposed that insurers publish an annual statement of which morbidity tables are used for each product, the jurisdiction of those tables, and the date of the last revision. This would not prevent all future problems, but it would reduce the information asymmetry that left Dutch policyholders exposed to a German actuarial shift.

Trade-Offs in Cross-Border Table Usage

While the Dutch LTC pool case highlights risks, there are also legitimate reasons insurers use foreign morbidity tables. Local tables may not exist for emerging risks, or may be based on small sample sizes with high volatility. German tables, by contrast, benefit from decades of data across a large population, making them statistically robust. For niche products like long-term care insurance, which is still relatively new in many European markets, foreign tables can provide a credible starting point.

However, the trade-off between statistical robustness and jurisdictional fit is rarely communicated to policyholders. A 2022 study by the European Actuarial Academy found that cross-border table usage was common in Central and Eastern European LTC products, where local data was sparse. In Poland, for example, several LTC policies used German tables with a 10% loading factor to adjust for higher Polish disability rates. That loading factor, while imperfect, at least acknowledged the basis risk.

The Dutch pool's product had no such loading. The German tables were applied directly, without any adjustment for Dutch morbidity patterns. This was a design choice that prioritized simplicity over accuracy. The pool's administrator could have commissioned a Dutch-specific study, but the cost—estimated at roughly €200,000–400,000 for a full morbidity study—was deemed prohibitive for a pool with only 15,000 policyholders.

Cost-benefit analyses of cross-border table usage should be part of the product approval process. Regulators could require insurers to demonstrate that the chosen tables are appropriate for the target market, or at least to quantify the basis risk. The AFM is reportedly considering such a requirement as part of its ongoing review of cross-border insurance products.

Counter-Arguments: Was the Cap Justified?

Not all stakeholders agree that the benefit cap was problematic. Some actuaries argue that the pool's solvency was genuinely threatened, and that the cap was a necessary measure to protect all policyholders. Without the cap, the pool might have become insolvent, leaving all claimants without benefits. In that sense, the cap can be seen as a fair allocation of a limited pool of funds.

Furthermore, the policy terms explicitly allowed benefit adjustments under material adverse deviation. Policyholders who signed the contract accepted that risk, even if they did not read the fine print. The Utrecht court's ruling supports this view: the insurer acted within its contractual rights.

However, consumer advocates counter that the fine print was buried in a 40-page policy document, and that the average policyholder could not reasonably be expected to understand the implications of cross-border table dependency. They argue that the principle of good faith requires insurers to highlight such risks prominently, not to hide them in boilerplate clauses.

The debate underscores a deeper tension in insurance regulation: how much risk should be borne by policyholders versus insurers? In Germany, regulators tilted the balance toward insurers by allowing premium increases. In the Netherlands, the balance tilted toward policyholders through benefit cuts. Neither approach is inherently fair; each reflects different regulatory philosophies about risk allocation.

Regulatory Gaps and Future Directions

The Dutch LTC pool case reveals several regulatory gaps. First, there is no European standard for morbidity table usage. EIOPA's 2023 consultation paper on cross-border insurance products noted that morbidity assumptions are often left to national regulators, creating a patchwork of disclosure requirements. A unified standard could reduce the risk of cross-border table dependency going undetected.

Second, solvency regulations like Solvency II do not explicitly address basis risk from foreign actuarial tables. The Dutch pool's solvency ratio dropped because reserves were calculated using the updated German tables, but the regulator had not required the pool to hold additional capital for the possibility of a table revision. A capital charge for cross-border basis risk could have absorbed some of the shock.

Third, policyholder protection mechanisms are inconsistent across jurisdictions. In Germany, policyholders had the right to reduce coverage instead of paying higher premiums—a choice that gave them some control. In the Netherlands, policyholders had no such option; the cap was imposed unilaterally. Standardizing policyholder rights when pricing assumptions change would improve fairness.

The AFM's ongoing review is expected to propose new rules by 2025. These may include mandatory disclosure of table jurisdiction, a requirement to offer local-table alternatives, and a cooling-off period for policyholders when table revisions are announced. Similar reviews are underway in Belgium and France, where regulators are examining cross-border dependency in their own LTC markets.

The case of the Dutch LTC pool is a cautionary tale for cross-jurisdiction insurance products. The convenience of using foreign tables must be weighed against the risk that those tables may change in ways that harm local policyholders. As the European insurance market becomes more integrated, regulators and insurers will need to develop standards that ensure products are priced for the markets they serve—not the markets they borrow from.

This article is for informational purposes only and does not constitute personalized insurance, legal, or financial advice. Readers should consult a qualified professional for advice specific to their situation.